Almost 15 to 20% of breast cancer cases are classified as triple negative breast cancer (TNBC) variants, which lack the expression of estrogen and progesterone receptors, and human epidermal growth factor receptor 2 (HER2) proteins on tumor cells (2). Here, ERBB2 is linked to breast cancer.